AAV-mediated liver-directed gene therapy for Acute Intermittent Porphyria: It is safe but is it effective?
AAV-mediated liver-directed gene therapy for Acute Intermittent Porphyria: It is safe but is it effective?
复制标题
AAV 介导的肝脏定向基因治疗急性间歇性卟啉症:安全但有效吗?
DOI:
10.1016/j.jhep.2016.07.006
复制
发表时间:
2016
影响因子:
25.7
通讯作者:
Brunetti-Pierri N
中科院分区:
文献类型:
--
作者:
Brunetti-Pierri N
登录
查看更多内容
影响因子:
15.9
作者:
Chandler, Randy J.;LaFave, Matthew C.;Venditti, Charles P.
通讯作者:
Venditti, Charles P.
影响因子:
7.3
作者:
Xiao X;Ni Y;Yu C;Li L;Mao B;Yang Y;Zheng D;Silvestrini B;Cheng CY
通讯作者:
Cheng CY
影响因子:
4.6
作者:
Dowman, Joanna K.;Gunson, Bridget K.;Mirza, Darius F.;Bramhall, Simon R.;Badminton, Mike N.;Newsome, Philip N.
通讯作者:
Newsome, Philip N.
影响因子:
25.7
作者:
D'Avola, Delia;Lopez-Franco, Esperanza;Gonzalez-Aseguinolaza, Gloria
通讯作者:
Gonzalez-Aseguinolaza, Gloria
影响因子:
9.3
作者:
Floderus, Y;Sardh, E;Harper, P
通讯作者:
Harper, P